Building the evidence base for shortened MDR-TB treatment regimens

Int J Tuberc Lung Dis. 2018 Jan 1;22(1):1-2. doi: 10.5588/ijtld.17.0776.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Africa
  • Antitubercular Agents
  • Clinical Protocols
  • Humans
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant*

Substances

  • Antitubercular Agents